Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy

NCT01961349 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy

Interventions

DRUG: Intralipid
DRUG: ICI35,868 (Diprivan)
DRUG: ICI35,868 (Diprivan) + EES0000645/A (SDS)

Sponsor

AstraZeneca

Collaborators

[object Object]